Skip to main content
NRX Pharmaceuticals, Inc.NP
SEC Form D filing

NRX Pharmaceuticals, Inc.

Biotech · Series A · Regulation D 506(b) · DE · Filed March 7, 2025

Offering amount
$3.5M
Exemption
Reg D 506(b)
Issuer state
DE
Filing date
March 7, 2025
Signature date
March 6, 2025
CIK
0001719406

Public filing directories

Browse directories that group public SEC Form D records by the same filing tags shown on this page. FormDFlow surfaces public-disclosure data from SEC EDGAR. Nothing here is investment advice.

Sector: BiotechMonth: March 2025Stage and month: Series A

Summary

Auto-generated

NRX Pharmaceuticals with $3.5M offering; biotech pharma company in series-a range.

Generated automatically by a language model from the public SEC filing; may contain errors. Verify against the source document on EDGAR. FormDFlow surfaces public-disclosure data from SEC EDGAR. Nothing here is investment advice.

Source

View on SEC EDGAR →Get alerts for filings like this →

FormDFlow surfaces public-disclosure data from SEC EDGAR. Nothing here is investment advice.